MedTrace Logo

Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma

NCT01482260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2012-11-06

No results posted yet for this study

Summary

Perturbations in microRNA (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). This study will be an exploratory analysis by miRNA expression profiling using microarrays.

Conditions

  • Cutaneous Malignant Melanoma

Interventions

PROCEDURE

Biopsy

Biopsy

Sponsors & Collaborators

  • Ruhr University of Bochum

    lead OTHER

Principal Investigators

  • Falk G Bechara, PD Dr. · Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum

  • Peter Altmeyer, Prof. Dr. · Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01482260 on ClinicalTrials.gov